- CA$5.09bn
- CA$4.74bn
- $483.11m
- 94
- 11
- 94
- 73
Annual income statement for Kinaxis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 224 | 251 | 367 | 427 | 483 |
| Cost of Revenue | |||||
| Gross Profit | 154 | 156 | 236 | 259 | 298 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 203 | 249 | 339 | 413 | 470 |
| Operating Profit | 20.8 | 1.92 | 27.9 | 14.1 | 12.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 21.5 | 1.1 | 31.5 | 19.7 | 25.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.7 | -1.17 | 20.1 | 10.1 | 0.056 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.7 | -1.17 | 20.1 | 10.1 | 0.056 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 13.7 | -1.17 | 20.1 | 10.1 | 0.056 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.488 | -0.231 | 0.702 | 0.345 | 0.746 |